Skip to main content
Clinical Trials/CTRI/2018/10/015956
CTRI/2018/10/015956
Not yet recruiting
Phase 2

A randomized controlled trial to study the effect of medication adherence tools in heart failure patients (MAT-HF)

AIIMS0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: I509- Heart failure, unspecified
Sponsor
AIIMS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AIIMS

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 18 to 60 years.
  • 2\) NYHA class 2 or 3 heart failure patients of either gender visiting the Cardiology OPD .
  • 3\) Referred patients from other clinics having previous prescription.
  • 4\) Participant willing to give informed consent.

Exclusion Criteria

  • 1\) Patient already recruited for other trial.
  • 2\) Patients with major organ dysfunction like renal dysfunction (Blood Urea \> 50mg%,
  • S.Creatinine \> 1\.8mg%) hepatic dysfunction (AST/ ALT/ ALP/ Total S. Bilirubin \> 3 times the
  • upper normal limit).
  • 3\) Pregnancy and lactation.
  • 4\) With other co\-morbid conditions like uncontrolled diabetes mellitus, uncontrolled
  • hypertension and malignancy.
  • 5\) Patients with rapidly progressing disease

Outcomes

Primary Outcomes

Not specified

Similar Trials